Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableNot Yet RecruitingNCT07751796What this trial is testingOptiCross HD IVUS for Assessing Invasion Depth in Upper Tract Urothelial CarcinomaWho this might be right forUpper Tract Urothelial Carcinoma Yonsei University 15
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT02793128What this trial is testingThe OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC StudyWho this might be right forCarcinoma, Transitional CellTransitional Cell Carcinoma of Renal Pelvis UroGen Pharma Ltd. 71
Testing effectiveness (Phase 2)UnknownNCT00005958What this trial is testingCombination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter Amgen
Not applicableLooking for participantsNCT01050504What this trial is testingCollecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerWho this might be right forLocalized Renal Pelvis and Ureter Urothelial CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone+8 more University of Washington 1,500
Testing effectiveness (Phase 2)Ended earlyNCT04228042What this trial is testingInfigratinib Before Surgery for the Treatment of Upper Tract Urothelial CancerWho this might be right forRenal Pelvis and Ureter Urothelial Carcinoma M.D. Anderson Cancer Center 15
Not applicableLooking for participantsNCT06598761What this trial is testingPostoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUCWho this might be right forUreter CancerRenal Pelvic CarcinomaAdvanced Urothelial Carcinoma Peking University First Hospital 60
Not applicableStudy completedNCT01138124What this trial is testingGabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)Who this might be right forRenal Pelvis CancerRestless Legs SyndromeEpilepsy+7 more GlaxoSmithKline 54,202
Testing effectiveness (Phase 2)Looking for participantsNCT06823427What this trial is testing9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial CarcinomaWho this might be right forUrothelial CarcinomaUrothelial Carcinoma BladderUrothelial Carcinoma Recurrent+1 more Mabwell (Shanghai) Bioscience Co., Ltd. 60
Not applicableUnknownNCT06181942What this trial is testingA Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Urological SurgeriesWho this might be right forUrological Surgeries Ruijin Hospital 15
Not applicableActive Not RecruitingNCT05696444What this trial is testingMedtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)Who this might be right forBladder CancerProstate CancerKidney Cancer+6 more Medtronic - MITG 144
Early research (Phase 1)Study completedNCT00623064What this trial is testingLapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter European Organisation for Research and Treatment of Cancer - EORTC 18
Testing effectiveness (Phase 2)Study completedNCT00471536What this trial is testingPazopanib in Treating Patients With Metastatic Urothelial CancerWho this might be right forDistal Urethral CancerProximal Urethral CancerRecurrent Bladder Cancer+5 more National Cancer Institute (NCI) 19
Early research (Phase 1)Looking for participantsNCT05614739What this trial is testingFORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3Who this might be right forUrinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms Eli Lilly and Company 677
Testing effectiveness (Phase 2)Looking for participantsNCT07667335What this trial is testingEnfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial CancerWho this might be right forLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+10 more Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT03219333What this trial is testingEnfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder CancerWho this might be right forCarcinoma, Transitional CellUrinary Bladder NeoplasmsUrologic Neoplasms+4 more Astellas Pharma Inc 219
Not applicableStudy completedNCT03662204What this trial is testingBlood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsWho this might be right forBreast CancerLung CancerColorectal Cancer+10 more Exact Sciences Corporation 5,133
Testing effectiveness (Phase 2)Study completedNCT00002914What this trial is testingPiritrexim in Treating Patients With Advanced Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Eastern Cooperative Oncology Group 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04953104What this trial is testingARID1A and/or KDM6A Mutation and CXCL13 ExpressionWho this might be right forLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+29 more M.D. Anderson Cancer Center 6